Reveal is closely following CDC guidelines to minimize the risk of COVID-19. At this time, we remain open for business and our clients’ studies are progressing as fast as possible, but may be subject to a slight delay.
ARTIFICIAL INTELLIGENCE IS REVOLUTIONIZING PATHOLOGY
Advanced pathology for preclinical research, clinical trials, and decision support
Advancing Research, Improving Patient Outcomes
Take advantage of our high quality histopathology research services to generate quantitative pathology end points.
Access the the most advanced AI-powered digital assay pathology platform in the cloud.
Clinical Decision Support
Incorporate AI-powered pathology decision support tools to improve patient outcomes.
Pathology Powered By
High quality immunohistochemistry (IHC) combined with whole slide imaging and cell-by-cell quantification to advance your research.
Access the most advanced quantitative NASH and fibrosis data from your human or rodent liver samples.
Data powered pathology for advanced research & better patient care
Latest research, in the news, or at events.
In a unique collaboration between multiple companies, Reveal has applied deep learning-based models to validate a diet-induced mouse NASH model that can be utilized in directed research studies for
Validation of an Off-the-Shelf, Diet-Induced NASH Mouse Model using Digital Whole Slide Scanning of Liver Tissue and Artificial Intelligence-Enabled, Quantitative Histopathological Analysis Download the PDF White Paper Summary: Non-alcoholic
Collaboration within the scientific community is essential for rapid progress. Our highly skilled team is ready to accelerate your COVID-19 research. In this time of uncertainty one thing is